CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced robust lobe-specific changes in white ...
The structural and functional organization of the brain as shown on MRI can predict the progression of brain atrophy in patients with early-stage, mild Parkinson's disease, according to a study ...
A long-term brain imaging study in aging adults showed faster rates of atrophy in certain brain structures to be associated with the risk of developing mild cognitive impairment (MCI). While some ...
Morning Overview on MSN
Routine brain scans may hide an early Alzheimer’s warning
Routine brain scans are starting to reveal something that was invisible to doctors a decade ago: subtle structural changes ...
Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.
Results obtained in the Phase 2 placebo-controlled CLEAR-MIND clinical trial showed that treatment with stem cell therapy laromestrocel was associated with a reduction in MRI measured ...
New research reveals that air pollution, especially PM2.5, may contribute to cerebral atrophy but does not seem to impair cognitive function. Urbanization affects the strength of this link. Study: ...
The White House released a statement on Dec. 1 from President Donald Trump's physician regarding his MRI scan. Here's what to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback